DRUG DESCRIPTION
ERWINAZE (asparaginase Erwinia chrysanthemi) contains an asparaginase
specific enzyme derived from Erwinia chrysanthemi. L-asparaginase is
a tetrameric enzyme consisting of four identical subunits, each having a molecular
weight of about 35 kDa. The activity of ERWINAZE is expressed in terms of International
Units.
ERWINAZE is supplied as a sterile, lyophilized, white powder in vials. Each
vial contains 10,000 International Units of asparaginase Erwinia chrysanthemi
and the following inactive ingredients: glucose monohydrate (5.0 mg), sodium
chloride (0.5 mg).
No comments:
Post a Comment